中华核医学杂志
中華覈醫學雜誌
중화핵의학잡지
CHINESE JOURNAL OF NUCLEAR MEDICINE
2001年
2期
71-73
,共3页
王铁%武秀朵%胡大一%李田昌%贾三庆%陈方
王鐵%武秀朵%鬍大一%李田昌%賈三慶%陳方
왕철%무수타%호대일%리전창%가삼경%진방
心肌梗塞%血栓溶解疗法%支架%MIBI
心肌梗塞%血栓溶解療法%支架%MIBI
심기경새%혈전용해요법%지가%MIBI
目的比较直接冠状动脉(简称冠脉)内支架置入和静脉溶栓疗法在急性心肌梗死(AMI)治疗中的效果。方法 42例急诊入院AMI患者,随机分为冠脉内支架组23例,静脉溶栓组19例。两组患者均于梗塞相关动脉(IRA)再通治疗前和后行99Tcm-甲氧基异丁基异晴(MIBI)心肌SPECT显像。将左室心肌分为20个节段,并对心肌摄取99Tcm-MIBI的程度进行打分,分别计算治疗前心肌显像的总积分(SBS)、治疗后心肌显像的总积分(SAS)和两者相减的积分(SDS)。结果直接冠脉内支架组与溶栓组比较:SBS为41.3±9.8和39.4±7.9(t=1.2,P>0.05),SAS为17.8±6.4和27.3±6.7(t=5.8,P<0.01),SDS为24.5±4.2和12.2±2.3(t=7.3,P<0.01)。在冠脉内支架组的总共460个心肌节段中,IRA再通治疗前有193个3分和4分节段,治疗后有106个改善至0分(54.9%)。在溶栓组的总共380个心肌节段中,溶栓前有149个3分和4分节段,溶栓后有61个节段改善至0分(40.9%),两组间的完全改善率差异有极显著性(P=0.014)。结论在AMI的急诊治疗中,直接冠脉内支架置入的疗效明显优于静脉溶栓疗法;99Tcm-MIBI心肌SPECT显像可对AMI患者IRA再通治疗疗效进行可靠的无创性评价。
目的比較直接冠狀動脈(簡稱冠脈)內支架置入和靜脈溶栓療法在急性心肌梗死(AMI)治療中的效果。方法 42例急診入院AMI患者,隨機分為冠脈內支架組23例,靜脈溶栓組19例。兩組患者均于梗塞相關動脈(IRA)再通治療前和後行99Tcm-甲氧基異丁基異晴(MIBI)心肌SPECT顯像。將左室心肌分為20箇節段,併對心肌攝取99Tcm-MIBI的程度進行打分,分彆計算治療前心肌顯像的總積分(SBS)、治療後心肌顯像的總積分(SAS)和兩者相減的積分(SDS)。結果直接冠脈內支架組與溶栓組比較:SBS為41.3±9.8和39.4±7.9(t=1.2,P>0.05),SAS為17.8±6.4和27.3±6.7(t=5.8,P<0.01),SDS為24.5±4.2和12.2±2.3(t=7.3,P<0.01)。在冠脈內支架組的總共460箇心肌節段中,IRA再通治療前有193箇3分和4分節段,治療後有106箇改善至0分(54.9%)。在溶栓組的總共380箇心肌節段中,溶栓前有149箇3分和4分節段,溶栓後有61箇節段改善至0分(40.9%),兩組間的完全改善率差異有極顯著性(P=0.014)。結論在AMI的急診治療中,直接冠脈內支架置入的療效明顯優于靜脈溶栓療法;99Tcm-MIBI心肌SPECT顯像可對AMI患者IRA再通治療療效進行可靠的無創性評價。
목적비교직접관상동맥(간칭관맥)내지가치입화정맥용전요법재급성심기경사(AMI)치료중적효과。방법 42례급진입원AMI환자,수궤분위관맥내지가조23례,정맥용전조19례。량조환자균우경새상관동맥(IRA)재통치료전화후행99Tcm-갑양기이정기이청(MIBI)심기SPECT현상。장좌실심기분위20개절단,병대심기섭취99Tcm-MIBI적정도진행타분,분별계산치료전심기현상적총적분(SBS)、치료후심기현상적총적분(SAS)화량자상감적적분(SDS)。결과직접관맥내지가조여용전조비교:SBS위41.3±9.8화39.4±7.9(t=1.2,P>0.05),SAS위17.8±6.4화27.3±6.7(t=5.8,P<0.01),SDS위24.5±4.2화12.2±2.3(t=7.3,P<0.01)。재관맥내지가조적총공460개심기절단중,IRA재통치료전유193개3분화4분절단,치료후유106개개선지0분(54.9%)。재용전조적총공380개심기절단중,용전전유149개3분화4분절단,용전후유61개절단개선지0분(40.9%),량조간적완전개선솔차이유겁현저성(P=0.014)。결론재AMI적급진치료중,직접관맥내지가치입적료효명현우우정맥용전요법;99Tcm-MIBI심기SPECT현상가대AMI환자IRA재통치료료효진행가고적무창성평개。
Objective To evaluate and compare the theraputic effectiveness of primary coronary stenting with that of intravenous thrombolysis therapy for acute myocardial infarction (AMI) using 99Tcm-MIBI myocardial SPECT imaging. Methods A tatal of 42 patients with AMI was undergoing primary coronary stenting (stenting group, 23 patients) or intravenous thrombolysis therapy (thrombolysis group, 19 patients). 99Tcm-MIBI myocardial SPECT imaging was performed before and 1-week after stenting or thrombolysis therapy. The left ventricular myocardium of each patient was divided into 20 segments. The semiquantitative score of myocardial 99Tcm-MIBI uptake was expressed with a five-point scoring system. The scores of scanning before stenting or intravenous thrombolysis was described as SBS,and the scores of scanning after stenting or intravenous thrombolysis was described as SAS. Deducting SAS from SBS resulted in SDS. Results The paired results of the stenting group vs thrombolysis group are as follows: SBS was 41.3±9.8 and 39.4±7.9 (t=1.2, P>0.05); SAS was 17.8±6.4 and 27.3±6.7 (t=5.8, P<0.01); SDS was 24.5±4.2 and 12.2±2.3 (t=7.3,P<0.01). In 193 defect segments before stenting, 106 segments (54.9%) recovered to normal after stenting. In 149 defect segments before intravenous thrombolysis, 61 segments (40.9%) recovered to normal after thrombolysis therapy. The comparison between stenting group and thrombolysis group in improved rate of the myocardial perfusion defect scores indicated that there was a significant difference (P<0.01). Conclusions 99Tcm-MIBI myocardial SPECT imaging has been proved to be an objective parameter for evaluating the therapeutic effectiveness of the stenting and intravenous thrombolysis in treatment of AMI. At the same time, the results indicate that primary coronary stenting seems to be more effective than intravenous thrombolysis.